Most cases of semaglutide not working are actually dosing or titration issues Nearly half of GLP-1 patients stop at 180 days due to side effects (52%), supply issues (33%), and cost (25%) A 2025 study found patients seeing an obesity specialist were 8 times more likely to stick with GLP-1s Rivas Medical Weight Loss has been treating obesity since 1991
Extended Dosing Horizons : By proving that cAMP levels can be pharmacologically sustained, this integrated protocol suggests that future GLP-1 treatments could be modified to last significantly longer, potentially reducing how frequently a patient must take the medication
Should I tell my prescriber I am taking quercetin with PT-141
Others might take longer to notice changes
Renee Rogers, PhD Understanding Exercise and GLP-1s (Anti-Obesity Medications) with Dr
The study also demonstrated the protective effect of exenatide on islet-cell function during GCs therapy, providing early evidence for using GLP-1 RAs to counteract the diabetogenic effects of GCs (34)